In-depth guide

UPDATED FEB 2026

Part of the Testosterone Therapy investigation

The short answer

The four primary qualifying injuries are: heart attack (myocardial infarction), stroke (ischemic or hemorrhagic), deep vein thrombosis (DVT), and pulmonary embolism (PE). Polycythemia that caused or contributed to a cardiovascular event may also qualify.

Injury must have occurred during or within 6 months of TRT use, and you must have used a qualifying TRT product for at least 30 days.

People's Justice Research TeamUpdated February 23, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

The testosterone therapy lawsuit covers injuries caused by the cardiovascular effects of testosterone replacement products. Qualifying injuries include heart attack (myocardial infarction), stroke (ischemic or hemorrhagic), deep vein thrombosis (DVT — blood clots in the legs), pulmonary embolism (PE — clots in the lungs), and polycythemia (elevated red blood cell count) that caused or contributed to a cardiovascular event.

Qualifying products include: AndroGel (AbbVie), Axiron (Eli Lilly), Androderm patch (Actavis/Allergan/Teva), Testim (Endo, via Auxilium), Fortesta (Endo, via Auxilium), Aveed (Endo), Depo-Testosterone (Pfizer), and generic testosterone products. The injury must have occurred while using the product or within approximately six months of use. Cases with clear prescription-to-injury timelines and strong medical records have the highest settlement value.

The full investigation

Part of the Testosterone Therapy Investigation